First Page | Meta Content | |
---|---|---|
Document Date: 2013-04-09 06:25:23Open Document File Size: 124,96 KBShare Result on FacebookCityThe Hague / Stuttgart / New York / Edinburgh / San Juan / /CompanyLangman Group / Oxford University Press / Wissenschaftliche Verlagsgesellschaft mbH / Zeneca Ltd. / Thomson Reuters / Therapeutic Drug Carrier Systems / J. Pharm / Rechtbank / Zeneca Pharmaceuticals / Eurand America INC / The Dow Chemical Company / Controlled Release Drug Delivery Systems / /CountryGermany / Puerto Rico / United States / Netherlands / /EventFDA Phase / Business Partnership / /FacilityNIK45 American College of Neuropsychopharmacology / US-District Court / Commercial Court / District Court / FEDERAL PATENT COURT / /IndustryTermInternet excerpt / pharmaceutical active agents / /MedicalConditionSchizophrenia / acute dystonia / acute dyskinesia / dystonia / /OrganizationAmerican Psychiatric Association / EPC / NIK45 American College of Neuropsychopharmacology / US-District Court of New Jersey / Federal Patent Court / European Patent Office / European Union / Oxford University / German Patent and Trademark Office / Commercial Court of Barcelona / Senate / /PersonMünzberg / Bodmeier / Psych / Marcel Dekker / Gerster / Kasper / Psychiatry / Guth / /PositionR. N. / Chairman and Judge / General / Judge / /Productpseudo / Seroquel / Koss P 4 Headphone/Headset / TM17 LexisNexis® / /ProvinceOrStateNew Jersey / New York / /PublishedMediumNeuropsychopharmacology / Financial News / /SocialTag |